Tirzepatide improves 24-hour BP in obesity-related hypertension
Feb 07, 2024
A reduction was noted in 24-hour systolic BP at 36 weeks with treatment at 5, 10 15 mg tirzepatide versus placebo.
AHA: Semaglutide cuts risk for CVD events in patients without diabetes
Nov 14, 2023
Findings seen over three years in adults with preexisting cardiovascular disease and overweight or obesity
Insulin out-of-pocket cost caps do not increase insulin use
Mar 26, 2024
Caps are associated with a reduction in insulin costs, mainly driven by patients enrolled in health savings accounts.
Prescription opioids linked to increased risk for serious fall events
Feb 20, 2024
The findings seen among adults of all ages, especially those aged 85 years or older; the risk was highest in the first 28 days after initiation.
Risk profile IDs COVID-19 patients who will benefit from baricitinib
Feb 26, 2024
Baricitinib plus remdesivir was linked to a reduced risk of death and progression to invasive mechanical ventilation.
Being in good shape tied to fewer mental health Rx
Sep 11, 2023
There was not an association noted between a reduced risk for medication use for adults aged 65 or more years.
Pfizer restarts production plant in North Carolina following tornado damage in July
Sep 26, 2023
Most of the damage happened at the plant’s storage facility rather than its medication production areas.
Statin use increased from 1999-2000 to 2013-2014, then plateaued
Dec 04, 2023
No change was seen in the proportion using statins from 2013-2014 to 2017-2018 for those with diabetes and with ASCVD risk greater than 20%.
Over-the-counter meds, exercise most prevalent treatment for chronic pain
Nov 20, 2023
The likelihood of using prescription opioids was higher for older persons, those with public insurance, and those with more severe pain, after adjustment for multiple factors.
ACC: Semaglutide beneficial in obesity-related heart failure, type 2 diabetes
Apr 09, 2024
Larger reductions were seen in heart failure-related symptoms and physical limitations for patients with HFpEF and type 2 diabetes.